HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomomichi Fujitani Selected Research

Piclozotan

3/2009Population pharmacokinetics of the selective serotonin 5-HT1A receptor partial agonist piclozotan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomomichi Fujitani Research Topics

Disease

1Neoplasms (Cancer)
12/2021
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2014
1Atopic Dermatitis (Atopic Eczema)
01/2014
1Mental Disorders (Mental Disorder)
03/2009
1Body Weight (Weight, Body)
03/2009
1Stroke (Strokes)
03/2009

Drug/Important Bio-Agent (IBA)

1Surface Antigens (Surface Antigen)IBA
12/2021
1Pharmaceutical PreparationsIBA
12/2021
1Immunoglobulin G (IgG)IBA
12/2021
1Immunoconjugates (Immunoconjugate)IBA
12/2021
1Chymases (Chymase)IBA
01/2014
16- (5- chloro- 2- methoxybenzyl)- 4- alarkylaminocarbonyl- 1,4- diazepane- 2,5- dioneIBA
01/2014
15-HT1A Serotonin ReceptorIBA
03/2009
1PiclozotanIBA
03/2009

Therapy/Procedure

1Immunomodulation
03/2009